Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name ...

Hence, researchers often simulate the brain as a network of coupled neural masses, each described by a mean-field model. These models capture the essential features of neuronal populations while ...

Funding from the NIH's National Institute on Drug Abuse (NIDA) will Support Development of ENA-001, an Agnostic Respiratory Stimulant, for Community Drug Overdose and as a Medical ...

Research into ENA-001 is also supported by the National Institute on Drug Abuse (NIDA) of the National Institutes of Health (NIH) under award number R44DA057133. The content of this document is the ...

Researchers at the University of Basel are able to test in parallel the effects of over 1,500 active substances on cell ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

The U.S. Food and Drug Administration (FDA) has approved Johnson & Johnson's nasal spray, Spravato (esketamine), as the first ...

we believe that DOP agonists have an unprecedented mechanism of action and have the potential to revolutionize depression treatment with superior efficacy and safety compared to existing drugs." ...

Antidepressants have been long marketed by drug companies to work by increasing ... scientists do not understand the exact mechanism of action of antidepressant medications, and why they have ...